UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of Acute myocardial infarction: The valsartan in Acute myocardial infarction (VALIANT) trial

Circulation (New York, N.Y.), 2004-09, Vol.110 (12), p.1572-1578

2004

Volltextzugriff (PDF)

Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study

Kardiologiia, 2021-03, Vol.61 (4), p.4-14

2021

Volltextzugriff (PDF)

EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Annals of the rheumatic diseases, 2007-03, Vol.66 (3), p.377-388

2007

Volltextzugriff (PDF)

Repetitive use of levosimendan for treatment of chronic advanced heart failure: Clinical evidence, practical considerations, and perspectives: An expert panel consensus

International journal of cardiology, 2014-06, Vol.174 (2), p.360-367

2014

Volltextzugriff (PDF)

Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction

Circulation (New York, N.Y.), 2005-06, Vol.111 (25), p.3411-3419

2005

Volltextzugriff (PDF)

Decompensation of Heart Failure in "Fragile" Patients: Clinical Features and Approaches to Therapy

Kardiologiia, 2024-02, Vol.64 (2), p.51-59

2024

Volltextzugriff (PDF)

Effects of sacubitril/valsartan in patients with cancer therapy-related heart failure

Terapevtic̆eskii arhiv, 2023-09, Vol.95 (7), p.560-567

2023

Volltextzugriff (PDF)

Prevalence of heart failure among hospitalized patient with T2D: results of a prospective observational multicenter study (CREDO)

Sakharnyĭ diabet, 2024-03, Vol.27 (1), p.4-14

2024

Volltextzugriff (PDF)

Effect of dapagliflozin on the dynamics of magnetic resonance imaging in patients with heart failure and atrial fibrillation

Terapevtic̆eskii arhiv, 2023-09, Vol.95 (9), p.776-781

2023

Volltextzugriff (PDF)

Prospects for use of Vericiguat in HFrEF: Implications of VICTORIA Trial Results. Advisory Board Summary

Kardiologiia, 2023-05, Vol.63 (4), p.3-10

2023

Volltextzugriff (PDF)

Acute decompensation of heart failure: state of the problem

Terapevtic̆eskii arhiv, 2022-10, Vol.94 (9), p.1047-1051

2022

Volltextzugriff (PDF)

Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease

Terapevtic̆eskii arhiv, 2022-11, Vol.94 (10), p.1188-1196

2022

Volltextzugriff (PDF)

Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis

Kardiologiia, 2022-06, Vol.62 (6), p.3-14

2022

Volltextzugriff (PDF)

SGLT2 inhibitors in acute decompensated heart failure, what do we know?

Terapevtic̆eskii arhiv, 2022-05, Vol.94 (4), p.565-571

2022

Volltextzugriff (PDF)

Treatment of patients with heart failure and preserved ejection fraction: reliance on clinical phenotypes

Kardiologiia, 2022-07, Vol.62 (7), p.44-53

2022

Volltextzugriff (PDF)

Three ages of spironolactone. Evolution of views on spironolactone capabilities in the treatment of patients with heart failure

Kardiologiia, 2022-07, Vol.62 (7), p.3-11

Ageev, F. T.

2022

Volltextzugriff (PDF)

Predictive value of QRS complex duration in patients with chronic heart failure and atrial fibrillation: retrospective study

Terapevtic̆eskii arhiv, 2022-05, Vol.94 (4), p.503-510

2022

Volltextzugriff (PDF)

Promising directions in the treatment of chronic heart failure: improving old or developing new ones?

Bi͡u︡lletenʹ Sibirskoĭ medit͡s︡iny, 2022-10, Vol.21 (3), p.181-197

2022

Volltextzugriff (PDF)

The ability of modern therapy to improve the prognosis of patients with HF: role of angiotensin neprilysin inhibitors and sodium-glucose cotransporter inhibitors

Kardiologiia, 2021-07, Vol.61 (6), p.4-10

2021

Volltextzugriff (PDF)

Treatment strategies for patients with atrial fibrillation and chronic heart failure

Terapevtic̆eskii arhiv, 2021-12, Vol.93 (12), p.1545-1550

2021

Volltextzugriff (PDF)

Decompensated heart failure with reduced ejection fraction: overcoming barriers to improve prognosis in the "vulnerable" period after discharge

Kardiologiia, 2021-12, Vol.61 (12), p.82-93

2021

Volltextzugriff (PDF)

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study

Terapevtic̆eskii arhiv, 2021-06, Vol.93 (6), p.713-723

Batyushin, Mikhail M.

2021

Volltextzugriff (PDF)

Analysis of mortality in patients with heart failure after de-compen-sation during long-term follow-up in specialized medical care and in real clinical practice

Kardiologiia, 2020-03, Vol.60 (4), p.91-100

2020

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Aktive Filter

SpracheRussisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(144)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(138)
Life Sciences & Biomedicine
(135)
Cardiac & Cardiovascular Systems
(86)
Cardiovascular System & Cardiology
(86)
Humans
(65)
General & Internal Medicine
(37)
Medicine, General & Internal
(37)
Heart Failure
(26)
Chronic Heart Failure
(25)
Heart Failure - Drug Therapy
(24)
Female
(21)
Male
(19)
Treatment Outcome
(19)
Aged
(18)
Middle Aged
(17)
Prognosis
(17)
Heart Failure - Physiopathology
(14)
Chronic Disease
(11)
Angiotensin-Converting Enzyme Inhibitors - Therapeutic Use
(9)
Follow-Up Studies
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of Acute myocardial infarction: The valsartan in Acute myocardial infarction (VALIANT) trial

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study

EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Repetitive use of levosimendan for treatment of chronic advanced heart failure: Clinical evidence, practical considerations, and perspectives: An expert panel consensus

Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction

Decompensation of Heart Failure in "Fragile" Patients: Clinical Features and Approaches to Therapy

Effects of sacubitril/valsartan in patients with cancer therapy-related heart failure

Prevalence of heart failure among hospitalized patient with T2D: results of a prospective observational multicenter study (CREDO)

Effect of dapagliflozin on the dynamics of magnetic resonance imaging in patients with heart failure and atrial fibrillation

Prospects for use of Vericiguat in HFrEF: Implications of VICTORIA Trial Results. Advisory Board Summary

Acute decompensation of heart failure: state of the problem

Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease

Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis

SGLT2 inhibitors in acute decompensated heart failure, what do we know?

Treatment of patients with heart failure and preserved ejection fraction: reliance on clinical phenotypes

Three ages of spironolactone. Evolution of views on spironolactone capabilities in the treatment of patients with heart failure

Predictive value of QRS complex duration in patients with chronic heart failure and atrial fibrillation: retrospective study

Promising directions in the treatment of chronic heart failure: improving old or developing new ones?

Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial

The ability of modern therapy to improve the prognosis of patients with HF: role of angiotensin neprilysin inhibitors and sodium-glucose cotransporter inhibitors

Treatment strategies for patients with atrial fibrillation and chronic heart failure

Decompensated heart failure with reduced ejection fraction: overcoming barriers to improve prognosis in the "vulnerable" period after discharge

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study

Analysis of mortality in patients with heart failure after de-compen-sation during long-term follow-up in specialized medical care and in real clinical practice

Aktive Filter

Suchergebnisse filtern